AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
(From Philippine Daily Inquirer)
Byline: Charles E. Buban
SUSTAINED RESEARCH OF drugs already in the market is proving beneficial as one drug approved for treatment of breast and lung cancer, is found to dramatically improve the survival of patients with advanced head and neck cancer.
Researchers from Dana-Farber Cancer Institute and Harvard Medical School reported that adding the drug docetaxel (Taxotere) to the standard two-drug chemotherapy combination improved their patients chance of survival by 30 percent.
The findings were presented at the American Society of Clinical Oncologys annual meeting.
The result is very …